Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jonathan Hundley"'
Publikováno v:
Annals of Vascular Surgery. 90:54-55
Autor:
Michael F. Daily, Jonathan Hundley, Daniel L. Davenport, Almudena Moreno Elola-Olaso, Roberto Gedaly
Publikováno v:
HPB. 14:136-141
BackgroundPostoperative infections are frequent complications after liver resection and have significant impact on length of stay, morbidity and mortality. Surgical site infection (SSI) is the most common nosocomial infection in surgical patients, ac
Autor:
Richard Charnigo, Brian P. Delisle, Charles L. Campbell, Bennet George, Alison L. Bailey, Gustavo Morales, Diego Alcivar-Franco, Yousef Darrat, Jonathan Hundley, Samy-Claude Elayi, Sun Moon Kim
Publikováno v:
World Journal of Cardiology
AIM To determine the prevalence of QT prolongation in a large series of end stage liver disease (ESLD) patients and its association to clinical variables and mortality. METHODS The QT interval was measured and corrected for heart rate for each patien
Autor:
Paul Angulo, George A. Davis, Daniel A. Lewis, Kelly A. Walsh, Timothy M. Clifford, Jonathan Hundley, Yevgeniya Gokun
Publikováno v:
The Annals of pharmacotherapy. 47(3)
BACKGROUND Pharmacologic prophylaxis for venous thromboembolism (VTE) in patients with chronic liver disease (CLD) presents a unique challenge because of coagulopathies associated with the disease. When evaluating whether these patients require VTE p
PKI-587 and sorafenib alone and in combination on inhibition of liver cancer stem cell proliferation
Autor:
Jonathan Hundley, Donald A. Cohen, Malay B. Shah, Michael F. Daily, Roberto Gedaly, Brett T. Spear, B. Mark Evers, Paul Angulo, Changguo Chen, Roberto Galuppo, Yolanda Musgrave
Publikováno v:
The Journal of surgical research. 185(1)
Deregulated Ras/Raf/mitogen-activated protein kinase and PI3 K/AKT/mTOR signaling pathways are significant in hepatocellular carcinoma proliferation (HCC). In this study we evaluated differences in the antiproliferative effect of dual PI3 K/Akt/mTOR
The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment
Autor:
Roberto, Gedaly, Paul, Angulo, Changguo, Chen, Kate Townsend, Creasy, Brett T, Spear, Jonathan, Hundley, Michael F, Daily, Malay, Shah, B Mark, Evers
Publikováno v:
Anticancer research. 32(7)
Deregulated RAS/RAF/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC). This study aimed to test the inhibitory effects of PI-103 (a small molecule inhibitor of PI3K and mTOR) and sorafenib as single agents and in c
Autor:
Michael F. Daily, Jonathan Hundley, Roberto Gedaly, Paul Angulo, B. Mark Evers, Changguo Chen
Publikováno v:
The Journal of surgical research. 176(2)
Background Deregulated Ras/Raf/MAPK and PI3K/AKT/mTOR signaling pathways are found in hepatocellular carcinoma (HCC). This study aimed to test the inhibitory effects of PKI-587 and sorafenib as single agents or in combination on HCC (Huh7 cell line)
Autor:
Jonathan Hundley, Roberto Gedaly, Aaron M. Williams, Michael F. Daily, Malay B. Shah, James T. Lee
Publikováno v:
Liver Transplantation. 18:993-994
Although numerous surgical and percu-taneous techniques have been suggested for the man-agement of different IVC complications, there is noconsensus about a standard method of treatment.Here we describe a unique case in which a liverallograft caused
Autor:
Alison L. Bailey, David C. Booth, Jonathan Hundley, Richard Charnigo, Sun M. Kim, Charles L. Campbell, Michael W. Faulkner
Publikováno v:
Journal of the American College of Cardiology. 61:E1289
Autor:
Jonathan Hundley, Michael F. Daily, Patrick P. McHugh, Paul Angulo, Roberto Gedaly, Daniel L. Davenport
Publikováno v:
Archives of Surgery. 147:99-99